Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen T Durant

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Cancer|February 9, 2012
Telomerase-independent paths to immortality in predictable cancer subtypesStephen T Durant
Cell Cycle (Georgetown, Tex.)|August 17, 2005
Good timing in the cell cycle for precise DNA repair by BRCA1Stephen T Durant, Jac A Nickoloff
Plos One|June 20, 2017
Small molecule inhibitors uncover synthetic genetic interactions of human flap endonuclease 1 (FEN1) with DNA damage response genesThomas A Ward, Peter J McHugh, Stephen T Durant
Cell Cycle (Georgetown, Tex.)|February 18, 2009
p53 methylation--the Arg-ument is clearStephen T Durant, Er Chieh Cho, Nicholas B La Thangue
Journal of Biomolecular Screening|February 22, 2013
Development of a high-throughput fluorescence polarization DNA cleavage assay for the identification of FEN1 inhibitorsClaire McWhirter, Michael Tonge, Helen Plant, et al.
Molecular and Cellular Biology|August 2, 2006
UV radiation induces delayed hyperrecombination associated with hypermutation in human cellsStephen T Durant, Kimberly S Paffett, Meena Shrivastav, et al.
Nature Cell Biology|November 18, 2008
Arginine methylation regulates the p53 responseMartin Jansson, Stephen T Durant, Er-Chieh Cho, et al.
Free Radical Biology & Medicine|July 1, 2015
Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative diseaseLauren E Tebay, Holly Robertson, Stephen T Durant, et al.
DNA Repair|June 19, 2009
DNA-PKcs and ATM co-regulate DNA double-strand break repairMeena Shrivastav, Cheryl A Miller, Leyma P De Haro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2023
ATM-Inhibitor AZD1390 Is a Radiosensitizer for Breast Cancer CNS MetastasisBen Yi Tew, Alex J Kalfa, Zeyi Yang, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Cancer|February 9, 2012
Telomerase-independent paths to immortality in predictable cancer subtypesStephen T Durant
Cell Cycle (Georgetown, Tex.)|August 17, 2005
Good timing in the cell cycle for precise DNA repair by BRCA1Stephen T Durant, Jac A Nickoloff
Plos One|June 20, 2017
Small molecule inhibitors uncover synthetic genetic interactions of human flap endonuclease 1 (FEN1) with DNA damage response genesThomas A Ward, Peter J McHugh, Stephen T Durant
Cell Cycle (Georgetown, Tex.)|February 18, 2009
p53 methylation--the Arg-ument is clearStephen T Durant, Er Chieh Cho, Nicholas B La Thangue
Journal of Biomolecular Screening|February 22, 2013
Development of a high-throughput fluorescence polarization DNA cleavage assay for the identification of FEN1 inhibitorsClaire McWhirter, Michael Tonge, Helen Plant, et al.
Molecular and Cellular Biology|August 2, 2006
UV radiation induces delayed hyperrecombination associated with hypermutation in human cellsStephen T Durant, Kimberly S Paffett, Meena Shrivastav, et al.
Nature Cell Biology|November 18, 2008
Arginine methylation regulates the p53 responseMartin Jansson, Stephen T Durant, Er-Chieh Cho, et al.
Free Radical Biology & Medicine|July 1, 2015
Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative diseaseLauren E Tebay, Holly Robertson, Stephen T Durant, et al.
DNA Repair|June 19, 2009
DNA-PKcs and ATM co-regulate DNA double-strand break repairMeena Shrivastav, Cheryl A Miller, Leyma P De Haro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2023
ATM-Inhibitor AZD1390 Is a Radiosensitizer for Breast Cancer CNS MetastasisBen Yi Tew, Alex J Kalfa, Zeyi Yang, et al.
Pageof 3